ATBPF Stock, Antibe Therapeutics Information

Antibe is a commercial stage pharmaceutical company focused on pain, inflammation and regenerative medicine. Antibe s lead drug, ATB , targets the global need for a safer non steroidal anti inflammatory drug NSAID for treating chronic pain and inflammation with non addictive medication. Antibe s subsidiary, Citagenix Inc. Citagenix , is a leader in Canada in the sales and marketing of tissue regenerative products servicing the dental and orthopaedic marketplaces. Since its inception in , Citagenix has become an important source of knowledge and experience in the Canadian medical device industry. Citagenix has grown a comprehensive portfolio of high quality, branded biologics and medical devices that promote bone regeneration. Citagenix is active in countries, operating in Canada through its direct sales teams, and internationally via a network of distributor partnerships.